Cyclin-dependent kinase inhibitor (roscovitine) suppresses growth and induces apoptosis by regulating Bcl-x in head and neck squamous cell carcinoma cells.

International journal of oncology

Volumn 21, Issue 1, 2002, Pages 95-101

  Mihara, Mariko ^a   Shintani, Satoru ^a   Kiyota, Akihisa ^a   Matsumura, Tomohiro ^a   Wong, David T W ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2L1 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; CYCLINE; ENZYME INHIBITOR; PROTEIN BCL 2; PROTEIN BCL X; PURINE DERIVATIVE; ROSCOVITINE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; HEAD AND NECK TUMOR; HUMAN; METABOLISM; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; BCL-X PROTEIN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL DIVISION; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; GENE EXPRESSION; HEAD AND NECK NEOPLASMS; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; PURINES; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 0036653127     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.21.1.95     Document Type: Article

References (0)